Nonsmall Cell Lung Cancer, Stage II

DBCOND0129475NeoplasmsRespiratory Tract Diseases

Nonsmall Cell Lung Cancer, Stage II is the indication for 2 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Non-small Cell Lung Cancer Stage II · Stage II Non-Small Cell Lung Cancer · Lung Cancer Non-Small Cell Stage II · NSCLC Stage II · NSCLC, Stage II
Classified under
Indicated drugs

Resolves to

Vocabularies
MedDRA10025051UMLSC0278505

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
36Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Nonsmall Cell Lung Cancer, Stage II share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In